Relmada Therapeutics Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.23

+0.07 (+1.68%)

As of Sep 22, 3:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +783.5% upside

Low Target $22.23

Average Target $37.37

High Target $43.38

Current Price $4.23

Current
$4.23

Target
$37.37

$22.23 $37.37 avg $43.38

Scenario Analysis

Bear Case

$22.23

425.5%

Low target

Base Case

$37.37

+783.5%

Avg target

Bull Case

$43.38

+925.5%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$8.00

-47.1% from high

52-Week Low

$1.47

+187.8% from low

Target vs 52W High

$37.37

+367.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%